Patient Square Capital is set to acquire Premier Inc. for $2.6 billion, enhancing Premier's operational flexibility in a rapidly evolving healthcare landscape.
Target Company Overview
Patient Square Capital has reached an agreement to acquire Premier Inc., a prominent healthcare services provider based in the United States, for a total cash consideration of $2.6 billion. This transaction aligns with the ongoing trend of private equity firms investing heavily in large-scale healthcare platforms, as reported by Reuters. Under the terms of the agreement, Premier's shareholders are set to receive $28.25 per share, representing a 9.7% premium over the company's last closing price. The deal is subject to necessary shareholder and regulatory approvals and is expected to be finalized in the first quarter of 2026.
Industry Overview in the United States
In the ever-evolving landscape of the U.S. healthcare industry, Premier plays a vital role by partnering with hospitals and health systems to enhance patient care and reduce operational costs. The company achieves this by facilitating coordinated purchasing of essential medical equipment and supplies. This strategic approach has positioned Premier as an integral player in healthcare services, especially as organizations face increasing pressures to optimize expenditures while delivering quality care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
In recent years, the U.S. healthcare sector has undergone significant transformations, driven by technological advancements, regulatory changes, and the increasing demand for value-based care. The complexi
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Supernus Pharmaceuticals, Inc. → Sage Therapeutics, Inc.
2025
SERB Pharmaceuticals → Y-mAbs Therapeutics
2025
Patient Square Capital
invested in
Premier Inc.
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $2,600M